STOCK TITAN

Context Therapeutics (CNTX) Total Assets by Year

CNTX NASDAQ

Context Therapeutics Inc. closed fiscal year 2025 with $68.5M in total assets, $8.0M in total liabilities and $60.5M in shareholder equity. Total assets fell 30.2% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Context Therapeutics Inc. has filed alongside them.

FY2025 annual
Total Assets $68.5M
Total Liabilities $8.0M
Total Equity $60.5M
YoY -30.2%
5Y CAGR +171.1%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CNTX Balance Sheet by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Total Assets$68.5M-30.2%$98.1M+510.9%$16.1M-57.7%$38.0M-26.0%$51.3M+10878.2%$467K
Total Liabilities$8.0M+180.4%$2.9M-31.8%$4.2M+30.7%$3.2M+5.7%$3.0M-82.6%$17.4M
Total Equity$60.5M-36.5%$95.3M+702.5%$11.9M-65.8%$34.8M-28.0%$48.3Mn/m-$16.9M

CNTX Balance Sheet by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Total Assets$46.1M-47.1%$58.9M-36.7%$68.5M-30.2%$79.2M-8.2%$87.2M-15.1%$93.0M+741.2%$98.1M+510.9%$86.3M+275.5%$102.7M+270.0%$11.1M-65.4%$16.1M-57.7%$23.0M-45.4%
Total Liabilities$8.0M+72.8%$6.7M+235.7%$8.0M+180.4%$6.1M+145.0%$4.6M+187.2%$2.0M-24.0%$2.9M-31.8%$2.5M-46.3%$1.6M-57.3%$2.6M-19.3%$4.2M+30.7%$4.6M+14.8%
Total Equity$38.2M-53.8%$52.2M-42.6%$60.5M-36.5%$73.2M-12.7%$82.5M-18.4%$91.0M+977.6%$95.3M+702.5%$83.9M+356.1%$101.1M+321.2%$8.4M-70.6%$11.9M-65.8%$18.4M-51.7%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More Context Therapeutics Inc. financials

Frequently Asked Questions

Context Therapeutics Inc. closed fiscal year 2025 with $68.5M in total assets, $8.0M in total liabilities and $60.5M in shareholder equity.

Context Therapeutics Inc. (CNTX) total assets fell by 30.2% year over year, from $98.1M to $68.5M in fiscal year 2025.

Across the 6 fiscal years this page covers, Context Therapeutics Inc. (CNTX) total assets went from $467K in fiscal year 2020 to $68.5M in fiscal year 2025.

Context Therapeutics Inc. (CNTX) reported $46.1M in total assets in Q2 2026. This represents a decrease of 47.1% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Context Therapeutics Inc. (CNTX) reported on that line in every period on record.